Literature DB >> 15105257

Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress.

Hyman M Schipper1.   

Abstract

Mechanisms responsible for the pathological deposition of redox-active brain iron in human neurological disorders remain incompletely understood. Heme oxygenase-1 (HO-1) is a 32-kDa stress protein that degrades heme to biliverdin, free iron, and carbon monoxide. In this chapter, we review evidence that (1) HO-1 is overexpressed in CNS tissues affected by Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and other degenerative and nondegenerative CNS diseases; (2) the pro-oxidant effects of dopamine, hydrogen peroxide, beta-amyloid, and proinflammatory cytokines stimulate HO-1 expression in some of these conditions; and (3) upregulation of HO-1 in astrocytes exacerbates intracellular oxidative stress and promotes sequestration of nontransferrin-derived iron by the mitochondrial compartment. A model is presented implicating glial HO-1 induction as a "final common pathway" leading to pathological iron sequestration and mitochondrial insufficiency in a host of human CNS disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105257     DOI: 10.1196/annals.1306.007

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  36 in total

Review 1.  Carbon monoxide as an endogenous vascular modulator.

Authors:  Charles W Leffler; Helena Parfenova; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-15       Impact factor: 4.733

2.  Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.

Authors:  Alessia Di Nardo; Ioannis Kramvis; Namjik Cho; Abbey Sadowski; Lynsey Meikle; David J Kwiatkowski; Mustafa Sahin
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

3.  Differential sensitivity of oligodendrocytes and motor neurons to reactive nitrogen species: implications for multiple sclerosis.

Authors:  Amy Bishop; Kimberly Green Hobbs; Asuka Eguchi; Stephanie Jeffrey; Lorraine Smallwood; Cedona Pennie; James Anderson; Alvaro G Estévez
Journal:  J Neurochem       Date:  2009-01-19       Impact factor: 5.372

Review 4.  Carbon monoxide and the CNS: challenges and achievements.

Authors:  Cláudia S F Queiroga; Alessandro Vercelli; Helena L A Vieira
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

5.  Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.

Authors:  Xiaofeng Xu; Ning Song; Ranran Wang; Hong Jiang; Junxia Xie
Journal:  Mol Neurobiol       Date:  2015-09-18       Impact factor: 5.590

6.  Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders.

Authors:  Thomas Stahnke; Christine Stadelmann; Anne Netzler; Wolfgang Brück; Christiane Richter-Landsberg
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

7.  Oxidative stress increases HO-1 expression in ARPE-19 cells, but melanosomes suppress the increase when light is the stressor.

Authors:  Anna Pilat; Anja M Herrnreiter; Christine M B Skumatz; Tadeusz Sarna; Janice M Burke
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

Review 8.  Cerebroprotective functions of HO-2.

Authors:  Helena Parfenova; Charles W Leffler
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 9.  The presence and role of iron in mild traumatic brain injury: an imaging perspective.

Authors:  Eric J Nisenbaum; Dmitry S Novikov; Yvonne W Lui
Journal:  J Neurotrauma       Date:  2014-01-09       Impact factor: 5.269

10.  Mechanisms of neuroprotection by hemopexin: modeling the control of heme and iron homeostasis in brain neurons in inflammatory states.

Authors:  Peter Hahl; Taron Davis; Cecilia Washburn; Jack T Rogers; Ann Smith
Journal:  J Neurochem       Date:  2013-02-25       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.